Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
fda
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
pfizer
4
×
san diego blog main
san diego top stories
clinical trials
san francisco blog main
san francisco top stories
abbvie
akcea therapeutics
alnylam pharmaceuticals
astrazeneca
avexis
biotech
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
detroit blog main
detroit top stories
drugs
eli lilly
genentech
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
johnson & johnson
microbiome
national
onpattro
patisiran
raleigh-durham blog main
What
fda
4
×
drug
alnylam
approved
bio
medicine
news
rnai
roundup
afternoon
alnylam’s
approves
august
biotech
busy
cells
companies
days
decisions
devices
digital
disease
drugs
ema
employ
epidemic
europe
fatty
follows
frenzied
gene
gets
growing
harmful
history
hits
interference
known
landmark
led
Language
unset
Current search:
pfizer
×
fda
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
